Baneen Ummul, Naseem Sufia
Department of Tuberculosis and Respiratory Medicine, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
Department of Biochemistry, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
J Family Med Prim Care. 2019 Jul;8(7):2268-2277. doi: 10.4103/jfmpc.jfmpc_404_19.
The global scenario of illness is shifting from infectious diseases to non-communicable diseases, with chronic conditions such as heart diseases, stroke and Chronic Obstructive Pulmonary Disease (COPD) now being chief causes of death globally and more than 90% of deaths due to COPD occur in low and midline income countries.[1] Low serum vitamin D level is associated with various lung diseases and decreased lung function.[2].
This study was designed to study the serum vitamin D level and its correlation with severity of COPD as assessed by spirometry, COPD assessment test (CAT) and exercise capacity and BMI of COPD patients.
Observational cross sectional study conducted on patients of COPD attending the outpatient department.
One hundred sixty consecutive patients of COPD attending the outpatient Department were included in the study. Pack years, CAT score, 6 minute walk distance, post bronchodilator spirometry values and BMI was recorded along with complete history and physical examination.
Data analysis was done using IBM SPSS 23 software. Descriptive statistics, Independent sample test, ANOVA and Pearson correlation were applied.
A significant positive correlation was found between FeV1% of predicted and serum Vitamin D level( = 0.291; < 0.001). A negative correlation was found between serum Vitamin D level and severity of COPD as assessed by CAT score ( = -0.355; < 0.001). Also, a significant positive correlation was found between vitamin D levels and exercise capacity as assessed by 6 minute walk test (6MsWT) ( = 0.648; < 0.001).
COPD patients with more severe disease tend to have lower serum Vitamin D levels. As it is an immunomodulator affecting various inflammatory pathways, it is imperative that we give due consideration to Vitamin D levels in managing patients of COPD.
全球疾病状况正在从传染病转向非传染性疾病,心脏病、中风和慢性阻塞性肺疾病(COPD)等慢性病现已成为全球主要死因,超过90%的COPD死亡发生在低收入和中等收入国家。[1]血清维生素D水平低与多种肺部疾病和肺功能下降有关。[2]
本研究旨在研究COPD患者的血清维生素D水平及其与通过肺活量测定、COPD评估测试(CAT)以及运动能力和BMI评估的COPD严重程度的相关性。
对在门诊就诊的COPD患者进行观察性横断面研究。
本研究纳入了160例连续在门诊就诊的COPD患者。记录了吸烟包年数、CAT评分、6分钟步行距离、支气管扩张剂后肺活量测定值和BMI,以及完整的病史和体格检查。
使用IBM SPSS 23软件进行数据分析。应用了描述性统计、独立样本检验、方差分析和Pearson相关性分析。
发现预测的第一秒用力呼气容积百分比(FeV1%)与血清维生素D水平之间存在显著正相关(r = 0.291;P < 0.001)。发现血清维生素D水平与通过CAT评分评估的COPD严重程度之间存在负相关(r = -0.355;P < 0.001)。此外,发现维生素D水平与通过6分钟步行试验(6MWT)评估的运动能力之间存在显著正相关(r = 0.648;P < 0.001)。
病情较重的COPD患者往往血清维生素D水平较低。由于维生素D是一种影响多种炎症途径的免疫调节剂,因此在管理COPD患者时必须充分考虑维生素D水平。